SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-11-008136
Filing Date
2011-05-17
Accepted
2011-05-17 16:29:31
Documents
1
Period of Report
2011-05-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 4303
  Complete submission text file 0001179110-11-008136.txt   5710
Mailing Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054 9092701400
WATSON PHARMACEUTICALS INC (Issuer) CIK: 0000884629 (see all company filings)

IRS No.: 953872914 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 626 HOMEWOOD AVENUE #107 HIGHLAND PARK IL 60035
Business Address
FELDMAN MICHEL J (Reporting) CIK: 0001236488 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13305 | Film No.: 11851959